Researchers at the Duke University Cancer Institute have found that H. pylori may lead to an increased risk of colorectal cancer, especially for people with color. People of color are more likely to b...
In addition to surgery, chemotherapy is the main treatment for gastric cancerAt present, the treatment of gastric cancer is still mainly surgical resection. Because of the majority of patients with g...
Lutathera (Lutetium 177) is the first radiopharmaceutical approved by the FDA for the treatment of certain gastrointestinal and pancreatic cancers. Every year, about 17,000 people are diagnosed with ...
A research team led by the National University Health System (NUHS) and Duke University School of Medicine used genomic technology to better understand intestinal metaplasia (IM), a known risk factor ...
Gastric cancer immunotherapy is still an exciting research area, especially the pd-1 inhibitors pembrolizumab (Keytruda) and nivolumab (Nivolumab, Opdivo).In the Phase III ONO-4538-12 trial, nivolumab...
It is not difficult to reduce the mortality rate of gastric cancer in a certain year, but it is difficult to continuously reduce it for 60 years.What did Japan do to reduce the incidence and death o...
Gastric cancer has no good targeted drugs in the past, all relying on cytotoxic drugs that "kill the enemy by a thousand and damage by 800", which has large side effects. In recent years, with the co...
A study published in "Intestine" showed that long-term use of proton pump inhibitors will double the risk of gastric cancer . Proton pump inhibitors are a class of drugs used to treat gastric acid r...
Related studies have found that patients with gastric cancer have obvious family aggregation: the first-degree relatives (ie parents and siblings) of gastric cancer patients have a three-fold higher...
The anterior lobe of the transverse colon and the pancreatic capsule and the serous membrane of the stomach originate from the same germ layer, and together form a small omental sac. Gastric cancer ce...